The study reported prevalence rates of 57.7%, 45.8%, and 28% according to the IDF, NCEP ATP III
, and World Health Organization (WHO) definitions, respectively.7 This present study aimed to determine the prevalence of MetS and its components among Saudi adults with T2DM using the WHO and ATP III
This study was conducted in hundred patients who presented with either CAD or CVA to know the prevalence of metabolic syndrome and its individual components in them as per NCEP: ATP III
2001 criteria which was revised in 2005.
MS was diagnosed according to the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III
), the adapted ATP III
(ATP III-A) (26,27), and the International Diabetes Federation (IDF) (28).
In males, the AUC of WC for diagnosing MS (IDF), MS (ATP III
), and MS (CDS) were 0.923, 0.838, and 0.849, respectively (Table 3).
Various groups including the World Health Organization (WHO) , European Group for the Study of Insulin Resistance , American Association of Clinical Endocrinologists , National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATP III
) , the International Diabetes Federation (IDF), and the American Heart Association (AHA) uniformly characterized MetS based on key cardiometabolic parameters  including obesity, elevated glucose, elevated blood pressure, hypertriglyceridemia, and low HDL cholesterol.
According to NCEP- ATP III
definition, an individual can be diagnosed with MetS when any of the three following components are present: WC (>102 cm for males and >88 cm for females); plasma triglycerides ([greater than or equal to] 150 mg/dl); HDL cholesterol (< 40 mg/dl for males and < 50 mg/dl for females); blood pressure ([greater than or equal to] 130/85 mm Hg), and fasting plasma glucose ([greater than or equal to] 110 mg/dl).
Frecuencia de sindrome metabolico en adultos mayores del Distrito de San Martin de Porres de Lima, Peru segun los criterios de ATP III
y de la IDF.
A recent survey in Central India observed an overall MetS prevalence as per the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III
) criteria to be 5.0% in the adult rural population.
Diagnosis of MetS was put forward according to the modified NCEP ATP III
En el ano 2001, el "National Cholesterol Education Program Adult Treatment Panel IN" (ATP III
) propone que el sindrome metabolico consiste en la presencia de al menos 3 de los siguientes factores: obesidad, hipertrigliceridemia, bajo HDL, hipertension, glicemia elevada o diabetes establecida (ATP III
La presente investigacion de tipo descriptivo, comparativa, transversal, observacional y no experimental, tuvo como objetivo determinar la influencia del consumo de grasas y carbohidratos como factores dieteticos en la aparicion de los componentes del Sindrome Metabolico (SM), la poblacion estuvo conformada por 171 pacientes con SM (ATP III
), 62 hombres y 109 mujeres entre 45 [+ o -] 14 anos a quienes se realizo evaluacion antropometrica, bioquimica y dietetica.
Out of thirty patients in each group two patients in group A, 5 in group B, 7 in group C and 10 patients in group D developed metabolic syndrome as per NCEP ATP III